These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33863308)
1. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis. Zhou LQ; Hu Y; Xiao HJ BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308 [TBL] [Abstract][Full Text] [Related]
2. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis. Hu Y; Ai LS; Zhou LQ PLoS One; 2021; 16(5):e0251202. PubMed ID: 33989301 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis. Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856 [TBL] [Abstract][Full Text] [Related]
5. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis. Wei D; Liu J; Ma J PeerJ; 2023; 11():e16014. PubMed ID: 37719125 [TBL] [Abstract][Full Text] [Related]
6. Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes. Münscher A; Prochnow S; Gulati A; Sauter G; Lörincz B; Blessmann M; Hanken H; Böttcher A; Clauditz TS Clin Oral Investig; 2019 Jan; 23(1):361-367. PubMed ID: 29671054 [TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis. Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884 [TBL] [Abstract][Full Text] [Related]
9. The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis. Yazdani J; Ghavimi MA; Jabbari Hagh E; Ahmadpour F Mol Diagn Ther; 2018 Oct; 22(5):523-535. PubMed ID: 30006812 [TBL] [Abstract][Full Text] [Related]
10. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis. Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Xun Y; Cao Q; Zhang J; Guan B; Wang M Oral Oncol; 2020 May; 104():104638. PubMed ID: 32182549 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma. Liu JL; Zhang XJ; Zhang Z; Zhang AH; Wang W; Dong JH PLoS One; 2013; 8(12):e83350. PubMed ID: 24386184 [TBL] [Abstract][Full Text] [Related]
13. The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis. Wang P; Xu L; Li L; Ren S; Tang J; Zhang M; Xu M Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):957-968. PubMed ID: 30747316 [TBL] [Abstract][Full Text] [Related]
14. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Yang L; Huang Y; Zhou L; Dai Y; Hu G Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654 [TBL] [Abstract][Full Text] [Related]
15. The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. de Ruiter EJ; Ooft ML; Devriese LA; Willems SM Oncoimmunology; 2017; 6(11):e1356148. PubMed ID: 29147608 [No Abstract] [Full Text] [Related]
16. Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis. Abdeyrim A; He S; Zhang Y; Mamtali G; Asla A; Yusup M; Liu J J Otolaryngol Head Neck Surg; 2020 May; 49(1):31. PubMed ID: 32471483 [TBL] [Abstract][Full Text] [Related]
17. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis. Chen Y; Cong R; Ji C; Ruan W Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589 [TBL] [Abstract][Full Text] [Related]
18. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis. Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis. Wan Y; Liu H; Zhang M; Huang Z; Zhou H; Zhu Y; Tao Y; Xie N; Liu X; Hou J; Wang C Head Neck; 2020 May; 42(5):1067-1076. PubMed ID: 32048783 [TBL] [Abstract][Full Text] [Related]
20. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis. Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]